Zymeworks Inc., a biotechnology company, develops biotherapeutics for the treatment of cancer, inflammation, and autoimmune diseases. The company's platforms include Azymetric multispecific antibody platform; Drug Conjugate platform that in...
Q2 2026
Aug 6, 2026
Q1 2026
May 7, 2026
FY 2025
Mar 2, 2026
Q4 2025
Q3 2025
Nov 6, 2025
